Drug baloxavir marboxil was initially developed by Japanese pharmaceutical company Shionogi but licensed the compound to Roche. The experimental antiviral drug helped improve flu symptoms faster than placebo in elderly or other high-risk patients, helping to strengthen Roche’s case that the new medicine could offset sliding revenues from its aging Tamiflu brand.

View article here

Source: Healthcare Dive

Pin It on Pinterest